IAIM
TXG icon

International Assets Investment Management’s 10x Genomics TXG Stock Holding History

International Assets Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,419
Closed -$860 – 1865
2024
Q3 		$860 Buy
+19,419
New +$401K ﹤0.01% 1184

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

International Assets Investment Management's TXG Position: Q4 2024 in Review

International Assets Investment Management sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 19,419 shares — an estimated $860 sold.

International Assets Investment Management first reported a position in TXG in Q3 2024 and held it in 1 quarter. The position peaked at $860 in Q3 2024. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • International Assets Investment Management reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 19,419 10x Genomics shares in Q4 2024, an estimated $860.
  • International Assets Investment Management first reported a position in 10x Genomics in Q3 2024 and held it in 1 quarter.
  • International Assets Investment Management's 10x Genomics position peaked at $860 in Q3 2024.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.